Zobrazeno 241 - 250
of 404
pro vyhledávání: '"Amer H. Zureikat"'
Autor:
Herbert J. Zeh, Adam Slivka, Nathan Bahary, Muaz Aijazi, Kevin McGrath, Marina N. Nikiforova, Jennifer Chennat, Amer H. Zureikat, Fasanella Kenneth, Kenneth K.C. Lee, Aatur D. Singhi, Somak Roy, Roderick J. O’Sullivan, Melissa E. Hogg, Michael A. Nalesnik, Randall E. Brand
Publikováno v:
Gastroenterology. 158:S-69
Autor:
Amer H. Zureikat, Aatur D. Singhi, Robert Lafyatis, Martin Wijkstrom, Celeste Shelton, Brandon M. Blobner, Rita Bottino, Jami L. Saloman, Randall E. Brand, David C. Whitcomb
Publikováno v:
Gastroenterology. 158:S-199
Autor:
Herbert J. Zeh, Amer H. Zureikat, Melissa E. Hogg, Mazen S. Zenati, Georgios I. Papachristou, Jennifer Chennat, John Nasr, Adam Slivka, Steven J. Hughes, Mordechai Rabinovitz, Asif Khalid, Rohit Das, Savreet Sarkaria, Andres Gelrud, Samer S. Al Masri, A.J. Moser, Kenneth K.C. Lee, Alessandro Paniccia, Wolfgang H. Schraut
Publikováno v:
Gastroenterology. 158:S-1536
Autor:
Amer H. Zureikat, Amr I. Al Abbas, Melissa E. Hogg, Herbert J. Zeh, Jae Pil Jung, Ahmad Hamad, Caroline J. Rieser, Mazen S. Zenati
Publikováno v:
Annals of Surgical Oncology. 27:965-965
In the original article, Caroline J. Rieser’s last name is spelled wrong. It is correct as reflected here.
Autor:
Dwight E. Heron, Amer H. Zureikat, Joshua L. Rodríguez-López, Steven A. Burton, Adam C. Olson, Nathan Bahary, Ankur K. Patel
Publikováno v:
Journal of Clinical Oncology. 38:755-755
755 Background: There is no consensus on treatment volumes for stereotactic body radiation (SBRT) in patients with pancreatic cancer (PCa). Herein, we report patterns of failure following adjuvant SBRT for close/positive margins in patients with panc
Autor:
Naomi Fei, Aatur D. Singhi, Pavan Rao, M.E. Hogg, Sijin Wen, Nathan Bahary, Rajesh Ramanathan, Brian A. Boone, Amer H. Zureikat, Herbert J. Zeh, Michael T. Lotze
Publikováno v:
Journal of Clinical Oncology. 38:761-761
761 Background: SMAD4, a tumor suppressor gene, is inactivated or deleted in 60-90% of pancreatic adenocarcinomas (PDA). Loss of SMAD4 allows tumor progression by limiting cell cycle arrest and apoptosis and increasing metastases. SMAD4 deficient PDA
Autor:
Kenneth K. Lee, Adam C. Olson, Jacob C. Hodges, Aatur D. Singhi, Steven A. Burton, Amer H. Zureikat, Asmita Chopra, Herbert J. Zeh, Nathan Bahary, M.E. Hogg, Michael T. Lotze, Brian A. Boone
Publikováno v:
Journal of Clinical Oncology. 38:727-727
727 Background: Neoadjuvant therapy is increasingly used for pancreatic cancer (PDA). The comparative efficacy of neoadjuvant chemotherapy (NC) versus chemoradiation (NCRT) remains uncertain. We aimed to compare NC and NCRT on survival outcomes and p
Autor:
T. Daum, Alessandro Paniccia, J. Holder-Murray, Mazen S. Zenati, Kristine M. Smith, Amer H. Zureikat, Amr I. Al Abbas, M. Boisen J Beane, S. Esper
Publikováno v:
HPB. 22:S40
Autor:
Adam Slivka, Rohit Das, Mazen S. Zenati, Anil K. Dasyam, Jennifer Chennat, Randal E. Brand, Samer AlMasri, Kenneth E. Fasanella, David L Bartlett, Amer H. Zureikat, Kenneth K. Lee, H.J. Zeh, Savreet Sarkaria, Kevin McGrath, Asif Khalid, Aatur D. Singhi
Publikováno v:
HPB. 22:S14
Autor:
Britney R. Harris, Kelsey A. Musgrove, James W. Marsh, H.J. Zeh, Carl Schmidt, Brian A. Boone, Amer H. Zureikat, Melissa E. Hogg
Publikováno v:
HPB. 22:S132